keyword
Keywords Pharmacology, drugs, drug inte...

Pharmacology, drugs, drug interactions and contraindications

https://read.qxmd.com/read/38545642/pharmamemory-an-interactive-animated-web-application-for-learning-autonomic-physiology-and-pharmacology
#1
JOURNAL ARTICLE
Timothy Rosencrans, Ryan Jones, Daniel Griffin, India Loyd, Anna Grady, Mary Moon, Frederick Miller
Intro Medical students face challenging but important topics they must learn in short periods of time such as autonomic pharmacology. Autonomic pharmacology is difficult in that it requires students to synthesize detailed anatomy, physiology, clinical skills, and pharmacology. The subject poses a challenge to learn as it is often introduced early in the medical school curriculum. Methods To ease the difficulty of learning autonomic pharmacology, we created a free web application, PharmaMemory (www.pharmamemory...
March 28, 2024: Advances in Physiology Education
https://read.qxmd.com/read/38541193/evaluating-knowledge-self-reported-confidence-levels-and-prescription-patterns-among-dental-practitioners-regarding-analgesics-in-dentistry-a-cross-sectional-study
#2
JOURNAL ARTICLE
Marija Badrov, Antonija Tadin
Background and Objectives : Dental pain is a common problem that often leads to unscheduled dental visits and requires a comprehensive understanding of analgesics, including their indications and contraindications. The aim of this study was to investigate dentists' knowledge, self-reported confidence levels, and prescribing patterns of analgesics in dentistry. Materials and Methods : A nationwide cross-sectional online survey was conducted, resulting in 379 responses. Of these, 68.6% were general dentists, and 31...
March 12, 2024: Medicina
https://read.qxmd.com/read/38529187/pharmacological-treatments-and-medication-related-problems-in-nursing-homes-in-catalonia-a-multidisciplinary-approach
#3
JOURNAL ARTICLE
Emilie Anderssen-Nordahl, Margarita Sánchez-Arcilla Rosanas, Montserrat Bosch Ferrer, Mònica Sabaté Gallego, Eladio Fernández-Liz, Antonio San-José, Maria Estrella Barceló-Colomer
Background: Aging correlates with increased frailty, multi-morbidity, and chronic diseases. Furthermore, treating the aged often entails polypharmacy to achieve optimal disease management, augmenting medication-related problems (MRPs). Few guidelines and tools address the problem of polypharmacy and MRPs, mainly within the institutionalized elderly population. Routine pharmacological review is needed among institutionalized patients. This pharmacological review may improve with a multidisciplinary approach of a collaboration of multiple health professionals...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38436193/clinical-pharmacist-intervention-in-contraindications-of-the-co-administration-of-cefoperazone-and-ambroxol-hydrochloride-injection
#4
JOURNAL ARTICLE
Z-Q Du, Y Jiang, R-R Lu, Q Zhou, H-H Zhu, Y Shen
BACKGROUND: Clinical pharmacists identified contraindications in two cases concerning the co-administration of cefoperazone and ambroxol hydrochloride injection, prompting a thorough investigation. CASE PRESENTATION: Clinically, two cases of contraindications for the co-administration of cefoperazone and ambroxol hydrochloride injection were discovered. After the intervention and analysis by clinical pharmacists, the possible reason could be the precipitation of free alkali due to the immediate administration of ambroxol after the infusion of cefoperazone...
February 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38282079/dabigatran-related-serious-medication-errors-an-analysis-using-data-from-vigibase
#5
JOURNAL ARTICLE
Qingxia Zhang, Qian Ding, Qun-Ying Yue
OBJECTIVE: To analyze the serious medication errors (MEs) on dabigatran, and their related factors, in order to avoid or reduce the occurrence of adverse events. METHODS: Serious MEs related to dabigatran were extracted from the WHO global database of reported potential side effects of medicinal products (VigiBase) by using "Medication errors and other product use errors and issues" High Level Group Term (HLGT) of the international Medical Dictionary for Regulatory Activities (MedDRA)...
January 29, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38075416/pharmacological-outlook-of-lenacapavir-a-novel-first-in-class-long-acting-hiv-1-capsid-inhibitor
#6
REVIEW
Giovanni Di Perri
The evolution of antiretroviral therapy is now addressed to develop regimens consisting of two instead of three drugs and it is also increasingly oriented to develop long-acting parenteral formulations in order to increase treatment adherence and to reduce the multifaceted individual burden associated to daily intake of drugs. This new way was first paved by the dual association consisting of the INSTI Cabotegravir and the NNRTI Rilpivirine, whose formulations allow for a single administration every two months...
2023: Le Infezioni in Medicina
https://read.qxmd.com/read/38068499/two-years-of-active-pharmacovigilance-surveillance-and-therapeutic-reconciliation-in-frail-populations-the-meap-3-0-study
#7
JOURNAL ARTICLE
Anna Bombelli, Greta Guarnieri, Niccolò Lombardi, Maria Giuseppa Sullo, Edoardo Spina, Giada Crescioli, Concetta Rafaniello, Giuseppe Cicala, Veronica Marangon, Rachele Folchino, Silvia Vecchio, Giulia Mosini, Sonia Radice, Emilio Clementi, Meap Group
Awareness related to the risk/benefit profile of therapies used in paediatric and elderly patients is limited. We carried out a study, called the MEAP 3.0 study, to collect and analyse evidence of adverse drug reactions (ADRs) and drug-drug interactions (DDIs) that occurred in frail populations under polypharmacy in a real-world setting. Data were retrieved from reports of ADRs and pharmacological counselling from patients treated in hospitals and territorial health services. We collected 2977 ADRs reports and identified 'anti-infectives for systemic use' and 'cardiovascular system' as the most frequently implicated pharmacological classes in under-18 and over-65 patients, respectively...
November 30, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38043331/insomnia-and-related-mental-health-conditions-essential-neurobiological-underpinnings-towards-reduced-polypharmacy-utilization-rates
#8
REVIEW
Michele Fornaro, Claudio Caiazza, Giuseppe De Simone, Flavia Rossano, Andrea de Bartolomeis
Insomnia represents a significant public health burden, with a 10% prevalence in the general population. Reduced sleep affects social and working functioning, productivity, and patient's quality of life, leading to a total of $100 billion per year in direct and indirect healthcare costs. Primary insomnia is unrelated to any other mental or medical illness; secondary insomnia co-occurs with other underlying medical, iatrogenic, or mental conditions. Epidemiological studies found a 40-50% comorbidity prevalence between insomnia and psychiatric disorders, suggesting a high relevance of mental health in insomniacs...
November 29, 2023: Sleep Medicine
https://read.qxmd.com/read/38035313/narrative-review-the-fda-s-perfunctory-approach-of-dietary-supplement-regulations-giving-rise-to-copious-reports-of-adverse-events
#9
REVIEW
WeiQi Li, Albert Wertheimer
Background : The Food and Drug Administration (FDA) originated from the passage of the 1906 Pure Food and Drugs act aimed to rein in the long-standing abuse in the consumer product marketplace. The act was passed to prohibit interstate commerce of misbranded and adulterated foods, drinks, drugs. Thus, promoting the FDA's mission to protect the public health by regulating human and veterinary drugs, biological products, medical devices, food supply, cosmetics, and tobacco to ensure safety, efficacy, and security...
2023: Innovations in Pharmacy
https://read.qxmd.com/read/38029231/drug-utilization-evaluation-of-erythropoietin-at-a-referral-teaching-hospital-in-iran
#10
JOURNAL ARTICLE
Iman Karimzadeh, Hanieh Rasekh, Ava Karimian, Mojtaba Shabani-Borujeni, Afsaneh Vazin
OBJECTIVES: Drug utilization evaluation (DUE) studies aim to survey the appropriateness of drug use. DUE is an executive approach used to improve the use of medications as well as reduce the cost of treatment, ensure drug adequacy, and improve patient safety. The aim of this study was to evaluate the pattern of erythropoietin use, according to standard guidelines, in patients admitted to Namazi Hospital in Shiraz, Iran. METHODS: In this descriptive, retrospective study, 230 patients were assessed...
2023: Advances in pharmacological and pharmaceutical sciences
https://read.qxmd.com/read/37962749/heart-failure-and-erectile-dysfunction-a-review-of-the-current-evidence-and-clinical-implications
#11
REVIEW
Maria Cristina Carella, Cinzia Forleo, Alessandro Stanca, Eugenio Carulli, Paolo Basile, Umberto Carbonara, Fabio Amati, Saima Mushtaq, Andrea Baggiano, Gianluca Pontone, Marco Matteo Ciccone, Andrea Igoren Guaricci
PURPOSE OF REVIEW: Heart failure (HF) and erectile dysfunction (ED) are two common conditions that affect millions of men worldwide and impair their quality of life. ED is a frequent complication of HF, as well as a possible predictor of cardiovascular events and mortality. ED deserves more attention from clinicians and researchers. RECENT FINDINGS: The pathophysiology of ED in HF involves multiple factors, such as endothelial dysfunction, reduced cardiac output, neurohormonal activation, autonomic imbalance, oxidative stress, inflammation, and drug side effects...
November 14, 2023: Current Heart Failure Reports
https://read.qxmd.com/read/37843351/prevalence-of-potential-drug-drug-interactions-among-intensive-care-unit-patients-receiving-linezolid-a-cross-sectional-study
#12
JOURNAL ARTICLE
H-Y Jiang, L-Y Yu, X Wang, Z-W Yu, Y-H Zhao
OBJECTIVE: Linezolid is commonly used in intensive care units (ICU) but has the potential to interact with other drugs. This study aimed to evaluate the prevalence of potential drug-drug interactions in ICU patients receiving linezolid. PATIENTS AND METHODS: Data of ICU patients receiving linezolid were extracted and included in the Hospital Prescription Analysis Program of China, and the risk of potential drug-drug interactions between concomitant drugs and linezolid was evaluated using the Lexicomp database...
October 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/37818695/exploring-signals-of-myopathy-associated-with-statin-and-contraindicated-comedications-in-the-realworld
#13
JOURNAL ARTICLE
Sewon Park, Ju Won Lee, Dal Ri Nam, Sun-Young Jung
BACKGROUND: Using statins in combination with other drugs was reported to increase the risk of myopathy. However, there was a sparse number of studies on the incidence of adverse events (AEs) associated with the concomitant use of statin and contraindicated drugs in the real world. OBJECTIVES: This study aimed to identify the risk of concomitant use of statins with contraindicated drugs by exploring signals related to statin-drug interactions. METHODS: We performed a disproportionality analysis for drugs and AEs by applying the case/non-case study using the KIDS-KAERS database (KIDS-KD), 2016-2020...
October 11, 2023: Fundamental & Clinical Pharmacology
https://read.qxmd.com/read/37790027/iatrogenic-side-effects-of-pain-therapies
#14
REVIEW
Christopher Gharibo, Asbjørn M Drewes, Frank Breve, Martina Rekatsina, Marco Antonio Narvaez Tamayo, Giustino Varrassi, Antonella Paladini
Pain regimens, particularly for chronic cancer and noncancer pain, must balance the important analgesic benefits against potential risks. Many effective and frequently used pain control regimens are associated with iatrogenic adverse events. Interventional procedures can be associated with nerve injuries, vascular injuries, trauma to the spinal cord, and epidural abscesses. Although rare, these adverse events are potentially catastrophic. Pharmacologic remedies for pain must also consider potential side effects that can occur even at therapeutic doses of over-the-counter remedies such as paracetamol (acetaminophen) or nonsteroidal anti-inflammatory drugs...
September 2023: Curēus
https://read.qxmd.com/read/37765269/a-drug-safety-concept-i-to-avoid-polypharmacy-risks-in-transplantation-by-individual-pharmacotherapy-management-in-therapeutic-drug-monitoring-of-immunosuppressants
#15
JOURNAL ARTICLE
Ursula Wolf
For several, also vital medications, such as immunosuppressants in solid organ and hematopoietic stem cell transplantation, therapeutic drug monitoring (TDM) remains the only strategy for fine-tuning the dosage to the individual patient. Especially in severe clinical complications, the intraindividual condition of the patient changes abruptly, and in addition, drug-drug interactions (DDIs) can significantly impact exposure, due to concomitant medication alterations. Therefore, a single TDM value can hardly be the sole basis for optimal timely dose adjustment...
September 10, 2023: Pharmaceutics
https://read.qxmd.com/read/37691593/current-clinical-application-of-dantrolene-sodium
#16
REVIEW
Hong Seuk Yang, Jae Moon Choi, Junyong In, Tae-Yun Sung, Yong Beom Kim, Shofina Sultana
Dantrolene sodium (DS) was first introduced as an oral antispasmodic drug. However, in 1975, DS was demonstrated to be effective for managing malignant hyperthermia (MH) and was adopted as the primary therapeutic drug after intravenous administration. However, it is difficult to administer DS intravenously to manage MH. MH is life-threatening, pharmacogenomically related, and induced by depolarizing neuromuscular blocking agents or inhalational anesthetics. All anesthesiologists should know the pharmacology of DS...
July 2023: Anesthesia and pain medicine
https://read.qxmd.com/read/37601502/anesthesiological-management-of-brugada-syndrome-patients-a-systematic-review
#17
REVIEW
Giuseppe Cuttone, Gennaro Martucci, Ruggero Napoli, Stefano Tigano, Antonio Arcadipane, Federico Pappalardo, Filippo Sanfilippo
Brugada syndrome (BrS) is a major risk factor for sudden cardiac death and ventricular tachyarrhythmias. Several drugs are contraindicated in patients with BrS, including some commonly administered drugs during anesthesia or in the perioperative period; however, there is still a paucity of evidence regarding BrS and common anesthetic pharmaceuticals. We conducted a systematic literature search (PubMed, updated October 10, 2022), including all studies reporting pharmacological management of BrS patients during anesthesia or intensive care, with a specific focus on proarrhythmic effects and possible pharmacological interactions in the context of BrS...
2023: Saudi Journal of Anaesthesia
https://read.qxmd.com/read/37519956/behavioral-and-dental-management-of-a-pediatric-patient-diagnosed-with-autoimmune-encephalitis-a-case-report
#18
Wejdan A Alowi, Khlood Baghlaf
BACKGROUND: This is a case report presenting the behavioral and dental management of a 9-year-old child recently diagnosed with autoimmune encephalitis, seizure disorder, and psychosis and treated with anticonvulsant and antidepressant medications. In this case, seizure semiology was presented as eye blinking during the attack, and the child was usually not conscious. It is absorbed by itself and associated with a post-sleeping attack that lasts for minutes. CASE DESCRIPTION: Parents presented to the pediatric dental clinic with a chief complaint of decayed teeth that needs to be restored...
2023: International Journal of Clinical Pediatric Dentistry
https://read.qxmd.com/read/37502215/potential-pharmacokinetic-interactions-with-concurrent-use-of-herbal-medicines-and-a-ritonavir-boosted-covid-19-protease-inhibitor-in-low-and-middle-income-countries
#19
REVIEW
Dallas J Smith, Huichang Bi, Josias Hamman, Xiaochao Ma, Constance Mitchell, Kumbukani Nyirenda, Tsitsi Monera-Penduka, Hellen Oketch-Rabah, Mary F Paine, Syril Pettit, Wihan Pheiffer, Richard B Van Breemen, Michelle Embry
The COVID-19 pandemic sparked the development of novel anti-viral drugs that have shown to be effective in reducing both fatality and hospitalization rates in patients with elevated risk for COVID-19 related morbidity or mortality. Currently, nirmatrelvir/ritonavir (Paxlovid™) fixed-dose combination is recommended by the World Health Organization for treatment of COVID-19. The ritonavir component is an inhibitor of cytochrome P450 (CYP) 3A, which is used in this combination to achieve needed therapeutic concentrations of nirmatrelvir...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37484883/hepatitis-c-virus-treatment-with-glecaprevir-and-pibrentasvir-in-patients-co-prescribed-carbamazepine-three-case-reports
#20
Michael Braude, Dilip T Ratnam, Louise Marsh, Joshua H Abasszade, Anouk T Dev
BACKGROUND: Highly effective and well-tolerated direct-acting antiviral (DAA) therapies have revolutionised the management of hepatitis C virus (HCV); however, niche populations face treatment barriers. DAAs co-prescribed with several first-generation anti-epileptic drugs (AEDs) are contraindicated due to drug-drug interactions. A common example is carbamazepine whereby steady-state carbamazepine reduces the maximum concentration and area under the curve of velpatasvir, glecaprevir and pibrentasvir due to potent cytochrome P450 (CYP) 3A4 induction...
July 5, 2023: World Journal of Gastrointestinal Pharmacology and Therapeutics
keyword
keyword
31094
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.